Key Insights

Highlights

Research Leaders

17 sponsors active, led by WiGeV Klinik Ottakring

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Not Yet Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT07376096Not Yet RecruitingPrimary

Liquid Biopsy in Germ Cell Tumors

Showing all 1 trials

Research Network

Active Sponsors

  • WiGeV Klinik Ottakring1
  • Landeskrankenhaus Salzburg1
  • Kantonsspital Graubünden1
  • Luzerner Kantonsspital1
  • Universitätsklinikum Krems1

Related Conditions

  • 100 Metastatic Patients1

Activity Timeline